Metraipolis › archive › dc_dd79d159b3e8

Sequencing Anti-CD19 Therapies in Diffuse Large B-Cell Lymphoma: From Mechanistic Insights to Clinical Strategies — Europe PMC PMID:40943582

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40943582
DOI
10.3390/ijms26178662
License (as archived)
solo-consultazione
Archived
2026-11-10T03:07:12.226Z
SHA-256 of the archived text
2cea2acacb2ccb660dad69d8bb9729c1401d0eaddf0c18d7a21c33e68e1ed6e3
Stable URL of this page
https://metraipolis.com/documento/dc_dd79d159b3e8

How to cite

Sequencing Anti-CD19 Therapies in Diffuse Large B-Cell Lymphoma: From Mechanistic Insights to Clinical Strategies — Europe PMC PMID:40943582 — Europe PMC (en), https://europepmc.org/article/MED/40943582 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dd79d159b3e8 (Metraipolis archive dc_dd79d159b3e8, sha256 2cea2acacb2ccb660dad69d8bb9729c1401d0eaddf0c18d7a21c33e68e1ed6e3)
BibTeX
@misc{dcdd79d159b3e8,
  title = {Sequencing Anti-CD19 Therapies in Diffuse Large B-Cell Lymphoma: From Mechanistic Insights to Clinical Strategies — Europe PMC PMID:40943582},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40943582},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dd79d159b3e8; sha256 2cea2acacb2ccb660dad69d8bb9729c1401d0eaddf0c18d7a21c33e68e1ed6e3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40943582. Agents can read the archived copy with the MCP tool read_document.